Showing results (741-750 of 4,512) with videos related to
Sort By:
Pageof 452
Future Oncology (London, England)|October 22, 2021
Large-scale omics data reveal the cooperation of mutation-circRNA-miRNA-target gene network in liver cancer oncogenesisJian Li, Chun-Peng Yu, Qun Li, et al.Future Oncology (London, England)|February 18, 2022
Prognostic role of red blood cell distribution width and platelet/lymphocyte ratio in early-stage classical Hodgkin lymphomaYunxia Tao, Yu Zhou, Haizhu Chen, et al.Future Oncology (London, England)|February 17, 2022
Xevinapant or placebo plus chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck: TrilynX phase III study designJean Bourhis, Barbara Burtness, Lisa F Licitra, et al.Future Oncology (London, England)|February 23, 2022
Role of adjuvant chemotherapy after concurrent chemoradiotherapy in patients with locally advanced cervical cancerLingna Kou, Tao Zhang, Xiling Yang, et al.Future Oncology (London, England)|February 25, 2022
Patient preferences for frontline therapies for Philadelphia chromosome-positive acute lymphoblastic leukemia: a discrete choice experimentAjibade Ashaye, Caitlin Thomas, Mehul Dalal, et al.Future Oncology (London, England)|April 26, 2019
Radiologic features of pneumonitis associated with nivolumab in non-small-cell lung cancer and malignant melanomaTomohisa Baba, Fumikazu Sakai, Terufumi Kato, et al.Future Oncology (London, England)|April 24, 2019
Safety and effectiveness of classical and alternative sunitinib dosing schedules for metastatic renal cell carcinoma: a meta-analysisSeye Abogunrin, Ajibade O Ashaye, Joseph C Cappelleri, et al.Future Oncology (London, England)|April 11, 2019
RATIONALE 301 study: tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinomaShukui Qin, Richard S Finn, Masatoshi Kudo, et al.Future Oncology (London, England)|April 13, 2019
Targeted therapies in urothelial bladder cancer: a disappointing past preceding a bright future?Joya-Rita Hindy, Tarek Souaid, Hampig Raphael Kourie, et al.Future Oncology (London, England)|May 2, 2019
PD-L1 expression and EGFR status in advanced non-small-cell lung cancer patients receiving PD-1/PD-L1 inhibitors: a meta-analysisJing Li, Jian GuPageof 452